New application of high resolution mass spectrometry and data mining tools in drug metabolite identi

来源 :2015年第一届药代动力学朝阳论坛 | 被引量 : 0次 | 上传用户:darkage12223
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Drug metabolism has become an integral part of drug discovery and development from the earliest stage, and this change may have been driven by the evolution of better analytical technologies, in particular the MS technique.High resolution mass spectrometry (HRMS) instruments and HRMS-based data acquisition and data mining technologies have been developed recently to enhance HRMS capabilities in the comprehensive and rapid identification of drug metabolites.As a result, LC-HRMS has become a key analytical platform for drug metabolite identification, which includes metabolic soft spot analysis, reactive metabolite screening, and metabolite profiling in vivo.
其他文献
  Metabolic profile of bile acids was used to evaluate hepatoprotec tion in Nrf2/ARE Oxidation/chemical stress defense pathway caused by Isoliquiritigenin (IS
会议
  Continuous exposure of breast cancer cells to adriamycin(Adr) induces high expression of P-gp and multiple drug resistance.However, the biochemical process
会议
  Bacterial β-glucuronidases in human colon play an important role in cleaving glucuronide conjugates of dietary compounds, endobiotics and xenobiotics.They
会议
  Dehydroepiandrosterone sulfotransferase (SULT2A1) plays an important role in the detoxification of hydroxyl-containing xenobitotics and in the regulation of
会议
  Drug ADME experiment in humans is a pivotal drug metabolism study in support of drug development and registration.Human ADME study provides information on t
会议
  Catechol-O-methyltransferase (COMT) plays a central role in the metabolic inactivation of endogenous catechols including catecholic neurotransmitters and es
会议
  TPN729MA is a novel selective phosphodiesterase type 5 (PDE5) inhibitor.The preclinical PK of TPN729MA was studied in rats and dogs.Human clearance (CL) val
会议
  When evaluating clinical drug-drug interactions (DDI), revealing whether and how the role of the metabolic status in the entire drug disposition in vivo aff
会议
  The circulating microRNAs (miRNAs) own many characteristics of biomarkers and can be released from platelet.We hypothesize plasma miRNA level can reflect th
会议
  Our study aimed at the investigation of in vivo anticancer effect of the combination use of dexamethasone (DEX) and gemcitabine (GM) as well as the developm
会议